继发性进行性多发性硬化的放射学疾病活动性。

IF 2.1 4区 医学 Q3 CLINICAL NEUROLOGY European Neurology Pub Date : 2023-01-01 DOI:10.1159/000527720
Daniela Noa Zohar, David Magalashvili, Sapir Dreyer-Alster, Chen Hoffmann, Gil Harari, Mark Dolev, Anat Achiron
{"title":"继发性进行性多发性硬化的放射学疾病活动性。","authors":"Daniela Noa Zohar,&nbsp;David Magalashvili,&nbsp;Sapir Dreyer-Alster,&nbsp;Chen Hoffmann,&nbsp;Gil Harari,&nbsp;Mark Dolev,&nbsp;Anat Achiron","doi":"10.1159/000527720","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>MRI activity is less frequent among secondary progressive multiple sclerosis (SPMS) patients. In the current study, we aimed to identify SPMS patients with higher radiological disease activity (RDA) and determine their clinical characteristics.</p><p><strong>Methods: </strong>We evaluated the occurrence of RDA in SPMS patients followed at the Sheba Multiple Sclerosis Center between January 1, 2015, and December 31, 2020. All patients underwent brain and spinal cord MRI examinations as a routine follow-up unrelated to clinical disease activity. Patients were subdivided into RDA and non-RDA MRI groups based on the presence of active gadolinium-enhancing T1 lesions and/or new/enlarging T2 lesions. Demographic variables and disease-related data were compared.</p><p><strong>Results: </strong>One hundred consecutive SPMS patients, 74 females, median age of 50 years, disease duration of 19.5 years, and neurological disability by the Expanded Disability Status Scale (EDSS) score of 6.0, were included in the study. The RDA group comprised 35 patients (35%), of them 65.7% (n = 23) exhibited only brain MRI activity, 22.8% (n = 8) only spinal cord MRI activity, and 11.4% (n = 4) had both. Patients in the RDA group were diagnosed at a younger mean (SD) age of 28.2 (8.9) versus 33.7 (10.1) years and were younger with a mean (SD) age of 47.8 (9.9) versus 53.4 (10.1) years, as compared with the non-RDA group. No significant differences were found in relation to disease duration, EDSS, exposure to immunomodulatory treatments, and duration of immunomodulatory treatments.</p><p><strong>Conclusions: </strong>RDA unrelated to clinical symptomatology was more frequent in a subgroup of young SPMS patients.</p>","PeriodicalId":12065,"journal":{"name":"European Neurology","volume":"86 2","pages":"116-120"},"PeriodicalIF":2.1000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Radiological Disease Activity in Secondary Progressive Multiple Sclerosis.\",\"authors\":\"Daniela Noa Zohar,&nbsp;David Magalashvili,&nbsp;Sapir Dreyer-Alster,&nbsp;Chen Hoffmann,&nbsp;Gil Harari,&nbsp;Mark Dolev,&nbsp;Anat Achiron\",\"doi\":\"10.1159/000527720\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>MRI activity is less frequent among secondary progressive multiple sclerosis (SPMS) patients. In the current study, we aimed to identify SPMS patients with higher radiological disease activity (RDA) and determine their clinical characteristics.</p><p><strong>Methods: </strong>We evaluated the occurrence of RDA in SPMS patients followed at the Sheba Multiple Sclerosis Center between January 1, 2015, and December 31, 2020. All patients underwent brain and spinal cord MRI examinations as a routine follow-up unrelated to clinical disease activity. Patients were subdivided into RDA and non-RDA MRI groups based on the presence of active gadolinium-enhancing T1 lesions and/or new/enlarging T2 lesions. Demographic variables and disease-related data were compared.</p><p><strong>Results: </strong>One hundred consecutive SPMS patients, 74 females, median age of 50 years, disease duration of 19.5 years, and neurological disability by the Expanded Disability Status Scale (EDSS) score of 6.0, were included in the study. The RDA group comprised 35 patients (35%), of them 65.7% (n = 23) exhibited only brain MRI activity, 22.8% (n = 8) only spinal cord MRI activity, and 11.4% (n = 4) had both. Patients in the RDA group were diagnosed at a younger mean (SD) age of 28.2 (8.9) versus 33.7 (10.1) years and were younger with a mean (SD) age of 47.8 (9.9) versus 53.4 (10.1) years, as compared with the non-RDA group. No significant differences were found in relation to disease duration, EDSS, exposure to immunomodulatory treatments, and duration of immunomodulatory treatments.</p><p><strong>Conclusions: </strong>RDA unrelated to clinical symptomatology was more frequent in a subgroup of young SPMS patients.</p>\",\"PeriodicalId\":12065,\"journal\":{\"name\":\"European Neurology\",\"volume\":\"86 2\",\"pages\":\"116-120\"},\"PeriodicalIF\":2.1000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European Neurology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000527720\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Neurology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000527720","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

MRI活动在继发性进行性多发性硬化症(SPMS)患者中较少发生。在本研究中,我们旨在识别具有较高放射疾病活动性(RDA)的SPMS患者并确定其临床特征。方法:我们评估了2015年1月1日至2020年12月31日在Sheba多发性硬化症中心随访的SPMS患者的RDA发生情况。所有患者均接受脑和脊髓MRI检查,作为与临床疾病活动无关的常规随访。根据活动性钆增强T1病变和/或新发/扩大T2病变的存在,将患者细分为RDA和非RDA MRI组。比较人口学变量和疾病相关数据。结果:连续纳入100例SPMS患者,女性74例,中位年龄50岁,病程19.5年,扩展残疾状态量表(EDSS)评分6.0分神经功能障碍。RDA组35例患者(35%),其中65.7% (n = 23)仅显示脑MRI活动,22.8% (n = 8)仅显示脊髓MRI活动,11.4% (n = 4)两者兼有。与非RDA组相比,RDA组患者的平均(SD)年龄更年轻,分别为28.2(8.9)岁和33.7(10.1)岁,平均(SD)年龄为47.8(9.9)岁和53.4(10.1)岁。在疾病持续时间、EDSS、免疫调节治疗暴露和免疫调节治疗持续时间方面没有发现显著差异。结论:与临床症状无关的RDA在年轻SPMS患者亚组中更为常见。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Radiological Disease Activity in Secondary Progressive Multiple Sclerosis.

Introduction: MRI activity is less frequent among secondary progressive multiple sclerosis (SPMS) patients. In the current study, we aimed to identify SPMS patients with higher radiological disease activity (RDA) and determine their clinical characteristics.

Methods: We evaluated the occurrence of RDA in SPMS patients followed at the Sheba Multiple Sclerosis Center between January 1, 2015, and December 31, 2020. All patients underwent brain and spinal cord MRI examinations as a routine follow-up unrelated to clinical disease activity. Patients were subdivided into RDA and non-RDA MRI groups based on the presence of active gadolinium-enhancing T1 lesions and/or new/enlarging T2 lesions. Demographic variables and disease-related data were compared.

Results: One hundred consecutive SPMS patients, 74 females, median age of 50 years, disease duration of 19.5 years, and neurological disability by the Expanded Disability Status Scale (EDSS) score of 6.0, were included in the study. The RDA group comprised 35 patients (35%), of them 65.7% (n = 23) exhibited only brain MRI activity, 22.8% (n = 8) only spinal cord MRI activity, and 11.4% (n = 4) had both. Patients in the RDA group were diagnosed at a younger mean (SD) age of 28.2 (8.9) versus 33.7 (10.1) years and were younger with a mean (SD) age of 47.8 (9.9) versus 53.4 (10.1) years, as compared with the non-RDA group. No significant differences were found in relation to disease duration, EDSS, exposure to immunomodulatory treatments, and duration of immunomodulatory treatments.

Conclusions: RDA unrelated to clinical symptomatology was more frequent in a subgroup of young SPMS patients.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
European Neurology
European Neurology 医学-临床神经学
CiteScore
4.40
自引率
4.20%
发文量
51
审稿时长
4-8 weeks
期刊介绍: ''European Neurology'' publishes original papers, reviews and letters to the editor. Papers presented in this journal cover clinical aspects of diseases of the nervous system and muscles, as well as their neuropathological, biochemical, and electrophysiological basis. New diagnostic probes, pharmacological and surgical treatments are evaluated from clinical evidence and basic investigative studies. The journal also features original works and reviews on the history of neurology.
期刊最新文献
SEX DIFFERENCES IN MARKERS OF CEREBRAL SMALL VESSEL DISEASE IN PATIENTS WITH LOBAR INTRACEREBRAL HEMORRHAGE. Effectiveness of Transcranial Direct Current Stimulation in Treating Drug-Resistant Focal Epilepsy: A Systematic Review and Meta-Analysis. Brain Evolution in the Times of the Pandemic and Multimedia. Causal Associations Between Tea Consumption and REM Sleep Behavior Disorder: A Mendelian Randomization Study. Continuous versus Routine Electroencephalography in the Intensive Care Unit: A Review of Current Evidence.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1